• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuroradiology . Acute hemorrhagic leukoencephalitis in a COVID-19 patient-a case report with literature review

tetano

Editor, Senior Moderator
Neuroradiology


. 2021 Feb 11.
doi: 10.1007/s00234-021-02667-1. Online ahead of print.
Acute hemorrhagic leukoencephalitis in a COVID-19 patient-a case report with literature review


Baskaran Varadan[SUP] 1 [/SUP], Abhinaya Shankar[SUP] 1 [/SUP], Akila Rajakumar[SUP] 2 [/SUP], Shubha Subramanian[SUP] 3 [/SUP], A C Sathya[SUP] 4 [/SUP], Abdul Rahman Hakeem[SUP] 5 [/SUP], Srinivasan Kalyanasundaram[SUP] 6 [/SUP]



Affiliations

Abstract

Purpose: Acute hemorrhagic leukoencephalitis (AHLE) is a rare and severe form of acute disseminated encephalomyelitis (ADEM). Only a few reports of AHLE in coronavirus disease 2019 (COVID-19) patients have been described to date. We report a case of COVID-19-related AHLE along with a literature review describing salient clinical and imaging characteristics.
Methods: A literature search was performed on Medline (2020-present), PubMed, Cochrane Library, CINAHL, and Google scholar on 28 January 2021 for all articles published using MeSH terms "COVID-19" or "SARS-CoV-2" with "Acute hemorrhagic leukoencephalitis" or "Acute hemorrhagic encephalitis." Relevant case reports and case series describing clinical and imaging features of AHLE associated with SARS-CoV-2 infection were included, data compiled, and critically reviewed.
Results: Acute onset encephalopathy and rapidly deteriorating neurological status is the common clinical presentation in AHLE. CSF analysis reveals elevated proteins and lymphocytic pleocytosis. Typical neuroimaging features include multifocal, variable-sized, poorly defined cerebral white matter lesions with cortical sparing. Involvement of the brainstem, cerebellar peduncles, and deep grey matter can also occur, although rarely. Lesions are hyperintense on T2-weighted (T2W) and fluid-attenuated inversion recovery (FLAIR) images, hypointense on T1W images, and show microhemorrhages, variable diffusion restriction, and post-contrast enhancement. Extensive microhemorrhages, brainstem involvement, and gross hemorrhage often portend a poor prognosis.
Conclusion: Heightened awareness about the clinical and imaging presentation of COVID-19-related AHLE can positively alter the outcome in a select few by enabling early diagnosis and aggressive management.

Keywords: Acute disseminated encephalomyelitis (ADEM); Acute hemorrhagic leukoencephalitis (AHLE); COVID-19; Computed tomography (CT); Magnetic resonance imaging (MRI).
 
Back
Top Bottom